Hidradenitis Suppurativa

Help Us In Our Search For A Prospective Hidradenitis Suppurativa Treatment.

Hidradenitis suppurativa manifests painful symptoms with localized to widespread skin lesions. It affects women three to five times as much as men. At present Adalimumab is the only approved medication for the management of hidradenitis suppurativa symptoms.

There are many unanswered questions surrounding the causes of HS and the painful and distressing symptoms it triggers in the body. With limited approved medical treatment options available, it’s important to keep looking for potential answers. Revival Research Institute is conducting clinical trials to assess the safety and efficacy of prospective treatments. 

Clinical research brings people together so join us and be a part of our interesting and possible life-changing discovery.

Could this study be an option for me? 

You may be able to take part in the study if: 

• you have a diagnosis of moderate to severe HS 
• you are 18 – 75 years of age 
• you have HS lesions in two different locations on your body

We hope that the results gained from the study will lead to further research and possible treatments for patients with HS. Our group of licensed and certified physicians will be keeping track of your progress throughout the study and will address any concerns or queries you may have about the research trial.